Genome-Wide Identification of Genes Essential for the Survival of Streptococcus pneumoniae in Human Saliva by Verhagen, L.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/135904
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Genome-Wide Identification of Genes Essential for the
Survival of Streptococcus pneumoniae in Human Saliva
Lilly M. Verhagen1, Marien I. de Jonge1, Peter Burghout1¤, Kiki Schraa1, Lorenza Spagnuolo1,
Svenja Mennens1, Marc J. Eleveld1, Christa E. van der Gaast-de Jongh1, Aldert Zomer1,2,
Peter W. M. Hermans1¤, Hester J. Bootsma1*
1 Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, the Netherlands, 2Centre for Molecular and
Biomolecular Informatics, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands
Abstract
Since Streptococcus pneumoniae transmits through droplet spread, this respiratory tract pathogen may be able to survive in
saliva. Here, we show that saliva supports survival of clinically relevant S. pneumoniae strains for more than 24 h in a
capsule-independent manner. Moreover, saliva induced growth of S. pneumoniae in growth-permissive conditions,
suggesting that S. pneumoniae is well adapted for uptake of nutrients from this bodily fluid. By using Tn-seq, a method for
genome-wide negative selection screening, we identified 147 genes potentially required for growth and survival of S.
pneumoniae in saliva, among which genes predicted to be involved in cell envelope biosynthesis, cell transport, amino acid
metabolism, and stress response predominated. The Tn-seq findings were validated by testing a panel of directed gene
deletion mutants for their ability to survive in saliva under two testing conditions: at room temperature without CO2,
representing transmission, and at 37uC with CO2, representing in-host carriage. These validation experiments confirmed that
the plsX gene and the amiACDEF and aroDEBC operons, involved in respectively fatty acid metabolism, oligopeptide
transport, and biosynthesis of aromatic amino acids play an important role in the growth and survival of S. pneumoniae in
saliva at 37uC. In conclusion, this study shows that S. pneumoniae is well-adapted for growth and survival in human saliva
and provides a genome-wide list of genes potentially involved in adaptation. This notion supports earlier evidence that S.
pneumoniae can use human saliva as a vector for transmission.
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Introduction
Streptococcus pneumoniae is the most common bacterial etiology of
community-acquired pneumonia in all ages, and can cause
outbreaks in closed settings. The most common manifestations
of pneumococcal disease include sinusitis, otitis media, pneumonia
and sepsis. The increasing antibiotic resistance and limited
serotype coverage of currently available vaccines demonstrates
the need for novel approaches in exploring new antimicrobials and
vaccines.
All pneumococcal disease begins with the establishment of
nasopharyngeal colonization. Once acquired, an individual
pneumococcal strain can be carried for weeks to months before
its eventual clearance [1]. Pneumococcal carriage induces the
production of both mucosal and systemic immunoglobulins.
Immunoglobulin G (IgG) and secretory IgA antibodies directed
against capsular polysaccharides and surface-associated proteins
have been observed in saliva of children in response to
colonization with S. pneumoniae [2,3]. The presence of anti-
pneumococcal IgA antibodies in saliva has been associated with
a lowered risk of pneumococcal acute otitis media (AOM), while
the serum IgG antibody level does not seem to be associated with
AOM risk [4]. This suggests that the presence of S. pneumoniae in
saliva is associated with the development of local pneumococcal
disease.
Transmission of S. pneumoniae, i.e. person-to-person spread, is
thought to occur through direct contact with the secretions of
colonized individuals. Commonplace activities such as talking,
coughing, and sneezing disseminate large amounts of respiratory
droplets that subsequently deposit on dry surfaces [5]. These
droplets carry bacteria and thus constitute a medium for
transmission of S. pneumoniae. Understanding of bacterial survival
in droplets is crucial for controlling infection transmission via
airborne aerosols and/or large droplet routes. Walsh et al.
demonstrated that S. pneumoniae can survive at ambient temper-
ature and humidity for at least four weeks [6]. For this and other
studies investigating the importance of fomites and dry surfaces in
microbial transmission (summarized in a systematic review by
Kramer et al. [7]), bacteria were suspended in Todd-Hewitt broth
supplemented with yeast extract (THY), distilled water or saline
solution. To our knowledge, the survival of S. pneumoniae in human
respiratory secretions has not yet been tested in a laboratory
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setting. Indirect evidence from studies in humans indicates that S.
pneumoniae can survive in saliva and that droplets of saliva may be
an important source of transmission of the bacterium. S. pneumoniae
was isolated from saliva of patients with stable chronic obstructive
pulmonary disease or asthma [8] and recently also from Dutch
children between 5 and 10 years of age [9]. Furthermore, in Israeli
army recruits frequent sharing of a drinking glass or bottle was an
independent risk factor for pneumococcal carriage, suggesting that
transmission of pneumococci may occur via saliva [10].
The aim of the current study was to examine the ability of S.
pneumoniae to survive and grow in human saliva and to identify the
genes essential for its survival in and transmission through saliva in
vitro. To this end, we examined the behavior of several
encapsulated and unencapsulated S. pneumoniae strains in human
saliva under two experimental conditions: at room temperature
(RT) without CO2, representing transmission, and at 37uC with
CO2, representing in-host carriage. Subsequently, S. pneumoniae
genes essential for survival in saliva under these two conditions
were identified using the genome-wide negative selection screen-
ings technology Tn-seq [11]. Finally, the roles of individual genes
identified by Tn-seq were validated in single and competitive in
vitro growth in human saliva.
Results and Discussion
Saliva concentration influences S. pneumoniae growth
and survival
In order to test if S. pneumoniae can survive in human saliva, 104
colony forming units (CFU) ml21 of strain Spain9V-3 (SP195) were
incubated with 100%, 50%, 25%, 12.5%, 6.25% and 0% saliva in
phosphate-buffered saline (PBS). Viable bacterial counts at t = 0,
t = 4 and t = 24 h post-inoculation were determined for two testing
conditions: RT without CO2 and 37uC with 5% CO2. At RT
without CO2, S. pneumoniae survived in 100% saliva and no
significant differences in viable bacterial counts between different
saliva concentrations were observed at t = 4 h (not shown). At
t = 24 h, the concentration of saliva did significantly affect the
survival of S. pneumoniae (p,0.01, Figure 1A left). The number of
viable counts was significantly lower in 0% saliva (100% PBS)
compared with all other concentrations of saliva (all p-values ,
0.01). Furthermore, viable bacterial counts in 6.25% and 12.5%
saliva were significantly lower than bacterial counts in 25%, 50%
or 100% saliva, with p-values varying from ,0.01 to 0.040. Viable
bacterial counts in 25% saliva did not differ significantly from
those in 50% or 100% saliva (Figure 1A left panel).
At 37uC with 5% CO2, significant differences in viable bacterial
counts between different saliva concentrations were observed at
t = 4 h (not shown) and at t = 24 h (Figure 1A right panel). The
number of bacteria was significantly lower in 0% 6.25% and
12.5% saliva compared with 25%, 50% and 100% saliva at both
time points with p-values varying from ,0.01 to 0.049.
Interestingly, at 37uC S. pneumoniae showed growth rather than
survival in 100%, 50% and 25% saliva with an increase in the
number of bacteria at t = 24 h compared with t = 0 h (Figure 1A,
right). This suggests that the pneumococcus is able to feed on and
grow in human saliva. Growth will lead to large S. pneumoniae cell
densities, a condition that may favor transmission of pneumococci
through droplet spread.
Because S. pneumoniae survival and growth were optimal in
undiluted saliva, all subsequently described experiments were
performed with 100% human saliva.
Bacterial inoculum size has no effect on growth and
survival of S. pneumoniae in saliva
To examine the influence of inoculum size on survival and/or
growth of pneumococci in human saliva, growth characteristics of S.
pneumoniae Spain9V-3 were monitored after inoculation of saliva with
four different starting inoculae (103, 104, 105 and 106 CFU ml21).
Interestingly, the bacterial inocolum size did not lead to major
differences in the growth characteristics of S. pneumoniae in saliva at
either growth condition (Figure 1B). At RT without CO2, CFU
counts remained near to constant from t= 0 to t = 24 h for all
bacterial starting inoculae. For all bacterial starting inoculae growth
at 37uCwith 5%CO2 was observed in the first 6 h after inoculation.
In all cases except for 103 CFU ml21, there was a subsequent
decline in CFUml21 between t = 6 and t = 24 h. These results show
that at 37uC saliva enables growth of S. pneumoniae until reaching a
maximum number of viable bacteria, after which growth of S.
pneumoniae diminishes (Figure 1B right). The maximum number of
CFU ml21 was found to be around 106 and was reached faster at
higher starting inoculae. A possible explanation for this observation
may be that nutrients present in saliva may become scarce as the
bacterial population expands until a threshold is reached when not
enough nutrients are present for all bacteria to survive.
Growth characteristics of S. pneumoniae in human saliva
are strain-specific
The ability to survive and/or grow in saliva was investigated for
a selection of S. pneumoniae strains. Globally significant antimicro-
bial-resistant clones identified by the Pneumococcal Molecular
Epidemiology Network (PMEN) with different serotypes were
selected [12]. Because we also wanted to assess the role of the
capsule for survival of pneumococci in saliva, two unencapsulated
strains (R6 and Spain9V-3 Dcps) and two non-typeable strains
(AHOY490 and AHOY2831) were included as well (Table 1).
Undiluted human saliva was inoculated with 104 CFU ml21 S.
pneumoniae. All tested S. pneumoniae strains survived in saliva at RT
in CO2-poor ambient air and at 37uC in a CO2-rich environment
(Figure 2A). At RT without CO2, most S. pneumoniae strains showed
survival in saliva with geometric mean viable bacterial counts at
t = 24 h around or below 100% of the bacterial starting inoculum
(Figure 2A left). At 37uC with 5% CO2 all PMEN strains showed
growth with geometric mean viable counts at t = 24 h at least 10-
fold higher than the number of bacteria at t = 0 h. The TIGR4
strain showed survival rather than growth at 37uC with 5% CO2
with geometric mean CFU around 10% of the bacterial starting
inoculum. The unencapsulated R6 strain also had a geometric
mean viable count at t = 24 h around 10% of the bacterial starting
inoculum. The unencapsulated derivative of Spain9V-3 (Spain9V-3
Dcps) and the non-typeable AHOY490 and AHOY2831 strains
showed growth at 37uC with CO2 with geometric mean viable
counts around 250% of the starting inoculum (Figure 2A right).
We also evaluated the ability of the unencapsulated derivative of
Spain9V-3 to survive and grow in saliva when in competition with
its wild-type parent. While no difference was seen after 4 h,
Spain9V-3 Dcps outcompeted its encapsulated wild type after 24 h
at both growth conditions (log CI.0, Figure 2B), demonstrating
that the capsule is not essential for the survival in saliva.
Interestingly, all PMEN strains showed much better survival in
saliva than the other strains tested at 37uC with 5% CO2, with the
exception of EF3030. Since all PMEN strains tested were of the
major clonal complex 156 and thus genetically related [13], their
similarity in behavior in human saliva may have a genetic basis.
The PMEN strains represent a group of important disease-causing
pneumococci isolated from patients from different parts of the
Survival of S. pneumoniae in Human Saliva
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world [12]. It is tempting to speculate that the wide geographical
distribution of the PMEN clones may be related to their increased
ability to grow in human saliva and transmit through droplet
spread. The epidemiological spread of PMEN clones is especially
worrisome because these clones consist of penicillin-resistant and
multidrug-resistant pneumococci and thus contribute to the
increase in antimicrobial resistance worldwide [12].
Identification of S. pneumoniae Spain9V genes essential
for growth and survival in saliva
To identify S. pneumoniae genes essential for growth and survival
in saliva, we employed the genome-wide negative selection screen
Tn-seq [11,14]. To this end, a large random S. pneumoniae Spain9V-
3 library was challenged by growth at RT in CO2-poor ambient
air and at 37uC in 5% CO2. Examination of the relative
abundance of each individual transposon mutant in the library
before challenge (starting condition) by Tn-seq revealed transpo-
son insertion mutants covered by at least 8 sequence reads in
26,289 unique TA-sites, representing a total of 1615 genes. Tn-seq
data can be found on the ESSENTIALS website (http://bamics2.
cmbi.ru.nl/websoftware/essentials/links.html).
Our screen identified 78 genes potentially required for survival
during 24 h in saliva at RT without CO2, as their corresponding
mutants were negatively selected from the mutant-library during
Figure 1. Optimal conditions for growth and survival of S. pneumoniae in saliva. A. Growth and survival of S. pneumoniae in saliva varies
with varying concentrations of saliva. Different dilutions of human saliva in PBS were inoculated with 104 CFU ml21 S. pneumoniae Spain9V-3 at RT
without CO2 (left) or at 37uC with CO2 (right). After 24 hours of incubation, viable bacterial counts of S. pneumoniae were determined and presented
as the percentage of the viable bacterial counts detected at t = 0 h. Each point represents a separate replicate. Horizontal lines indicate geometric
means. Saliva concentrations for which CFU ml21 significantly differed from 0% saliva by ANOVA and Tukey post-hoc tests are marked with an
asterisk (*). Percentages of saliva for which CFU ml21 significantly differed from 100% saliva by ANOVA and Tukey post-hoc tests are marked with a
black box (&). B. Effect of bacterial inoculum size on survival and growth of S. pneumoniae Spain9V-3 in saliva. Different number of starting CFU were
incubated in 100% saliva at RT without CO2 (left) or at 37uC with CO2 (right) for indicated periods. Data points represent the geometric mean of three
replicate experiments. Vertical lines represent the standard deviations of log10 transformed values.
doi:10.1371/journal.pone.0089541.g001
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Table 1. Bacterial strains, primers and plasmids used in this study.
Strain, primer or plasmid Relevant features or nucleotide sequence (59 to 39)a Reference/source or target geneb
S. pneumoniae strains
Spain6B-2 Serotype 6B; PMEN No. 2 [13]
Spain9V-3 Serotype 9V; PMEN No. 3 (SP195) [13]
Hungary19A-6 Serotype 19A; PMEN No. 6 [13]
South Africa6B-8 Serotype 6B; PMEN No. 8 [13]
Finland6B-12 Serotype 6B; PMEN No. 12 [13]
Poland23F-16 Serotype 23F; PMEN No. 16 [13]
Maryland6B-17 Serotype 6B; PMEN No. 17 [13]
Greece6B-22 Serotype 6B; PMEN No. 22 [13]
Colombia23F-26 Serotype 23F; PMEN No. 26 [13]
EF3030 Serotype 19F [49]
TIGR4 Serotype 4 [50]
DamiACDEF amiACDEF deletion mutant in strain Spain9V-3 This study
DaroDEBC aroDEBC deletion mutant in strain Spain9V-3 This study
DplsX plsX deletion mutant in strain Spain9V-3 This study
R6 Unencapsulated [51]
Spain9V-3 Dcps Capsule (cps) deletion mutant of Spain9V-3 This study
AHOY490 Non-typeable [52]
AHOY2831 Non-typeable [52]
Primers Deletion mutant
construction
amiACDEF_L1 AGATCGTTTTAAGTCTGACGCAG amiACDEF; left flank
amiACDEF_L2 CCACTAGTTCTAGAGCGGCCATGCTGCAAGTACACCTGC amiACDEF; left flank
amiACDEF_R1 GAGAAGTCAAGAGGAGCCCC amiACDEF; right flank
amiACDEF_R2 GCGTCAATTCGAGGGGTATCTTGTAGCAACGGTTCTGGCG amiACDEF; right flank
amiACDEF_C CAAGGTTTCTGGGTCTGCTG amiACDEF; control
aroDEBC_L1 GGAGGAGCTAGCCAGACAAC aroDEBC; left flank
aroDEBC_L2 CCACTAGTTCTAGAGCGGCAGCCTCCTCTAAACTTCTTGGC aroDEBC; left flank
aroDEBC_R1 ACAAAGCGAACAGACTTGCC aroDEBC; right flank
aroDEBC_R2 GCGTCAATTCGAGGGGTATCTTGTAGCAACGGTTCTGGCG aroDEBC; right flank
aroDEBC_C GAAAACCAACTCACGGCCTG aroDEBC; control
plsXSP195_0075_L1 TGGAGTTGATGGAAGCAGGC plsXSP195_0075; left flank
plsXSP195_0075_L2 CCACTAGTTCTAGAGCGGCATGGCCTGAGGTGCGTAATC plsXSP195_0075; left flank
plsXSP195_0075_R1 TCCAAATCTTGAATTGGCATCG plsXSP195_0075; right flank
plsXSP195_0075_R2 GCGTCAATTCGAGGGGTATCCAGACTGCGCGTGAATTTTC plsXSP195_0075; right flank
plsXSP195_0075_C TGTCGCTGTCAGATATTGCTTG plsXSP195_0075; control
Mutant validation by qRT-PCR
amiACDEF_F AGCATGGTTGACAGATAGTTCACTCT amiACDEF; forward
amiACDEF_R AATGGAACAATTCGTGAAAGCA amiACDEF; reverse
aroDEBC_F GGATGCCGACATCATTGAATG aroDEBC; forward
aroDEBC_R GGCTGGAGCTACCTGCAAAA aroDEBC; reverse
plsXSP195_0075_F GGAGATGAAGCTAAAATCAAGCAA plsXSP195_0075; forward
plsXSP195_0075_R TCATCATCCGAATCAATCTTCTCA plsXSP195_0075; reverse
gyrA_F AATGAACGGGAACCCTTGGT gyrA; forward
gyrA _R CCATCCCAACCGCGATAC gyrA; reverse
Plasmid
pGSF8 PCR2.1 with marinerT7-MmeI; Apr, Kmr, Spr [14]
Tn-seq
PBGSF23 CAAGCAGAAGACGGCATACGAAGACCGGGGACTTATCATCCAACCTGT GSF amplification primer 1
PBGSF29 ATCACG TTCCCTACACGACGCTCTTCCGATCTATCACGNN Adapter primer [14]
Survival of S. pneumoniae in Human Saliva
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challenge (defined as at least 2-fold attenuated survival at 24 h
compared with the starting library). After 4 h incubation at 37uC
with 5% CO2, mutants of 112 genes were attenuated at least 2-
fold. The overlap between genes involved in survival of S.
pneumoniae in both conditions was substantial: 55 genes were
identified as essential in both conditions (Figure 3A).
Genes involved in cell envelope biosynthesis are
essential for survival of S. pneumoniae in saliva
Functional annotation of the genes selected in either one or both
of the challenge conditions (n = 135) revealed that, next to genes
with an as yet unknown function, the two most important
functional categories were transport and cell envelope biosynthesis
(Table S1, Figure 3B). The pneumococcal cell envelope consists of
a plasma membrane, the cell wall and the capsule. The cell wall is
mainly composed of peptidoglycan (PG) and teichoic acids.
Several genes identified as important for the survival of S.
pneumoniae in saliva in our study contribute to resistance to
antimicrobial peptides (AMPs) and lytic enzymes produced by the
host, such as genes belonging to the murMN operon, plsX and pgdA
(Table S1). In saliva, positively charged AMPs with membrane-
damaging activity and antimicrobial PG lytic enzymes such as
lysozyme constitute a first line of defense against infection [15].
Inactivation of murMN or the pgdA gene has been shown to result in
hypersensitivity to lysis by lysozyme [16,17]. We observed that
mutants of murMN and pgdA were attenuated in saliva, probably
because of their increased sensitivity to lysis by lysozome.
Interestingly, pneumococcal cells in which murMN was inactivated
completely lost penicillin resistance [18,19]. This implies that
inhibitors of murMN would not only potentially decrease survival of
S. pneumoniae in saliva, they may also act as powerful synergists of
penicillin against resistant S. pneumoniae strains.
Other attenuated mutants in the functional category of cell
envelope biosynthesis included the ortholog of OatA, encoded by
SP195_2011 in Spain9V-3 and by SP_2057 in TIGR4. OatA is
responsible for O-acetylation of N-acetylmuramyl residues of
peptidoglycan, forming N,6-O-diacetylmuramic acid. O-acetyla-
tion of the peptidoglycan is the major determinant for lysozyme
resistance in Staphylococcus aureus [20] and a similar phenotype was
observed for S. pneumoniae and Lactococcus lactis oatA mutants
[21,22]. Interestingly, the regulator Spx, encoded by
SP195_A0021 in Spain9V-3 and by SP_0189 in TIGR4, was also
found to be attenuated. Spx was found to be responsible for
regulating the level of O-acetylation of peptidoglycan in L. lactis
[22].
In pneumococci as well as in other gram-positive bacteria, the
cell wall envelopes the plasma membrane which consists of
phospholipids and various proteins. The plsX gene plays a role in
the production of a fatty acid that is involved in membrane
phospholipid synthesis in S. pneumoniae and represents a new target
for the development of antibacterial therapeutics [23]. Since we
observed that the plsX gene was important in survival of S.
pneumoniae in human saliva, such new therapeutic agents may also
play a role in the prevention of droplet transmission of S.
pneumoniae. We hypothesize that the synthesis of fatty acids
mediated by plsX is of extra importance for the maintenance of
the membrane integrity in a fatty-acid poor environment, such as
human saliva [24]. Interestingly, the ortholog of the regulator
controlling fatty acid biosynthesis in L. lactis [25], encoded by
SP195_0456 in Spain9V-3 and by SP_0416 in TIGR4, was also
attenuated, suggesting that this regulator plays a similar role in S.
pneumoniae.
Several other genes identified as essential for pneumococcal
growth in saliva, such as nagA and glmS, are known key factors
involved in cell wall biosynthesis in other bacteria [26], although
their roles in S. pneumoniae are not yet fully understood.
Genes involved in transport, stress response and amino
acid metabolism are essential for survival of S.
pneumoniae in saliva
The largest functional category for which genes were identified
by the Tn-seq screening was transport while stress response and
amino acid metabolism were respectively third- and fourth-largest
(Figure 3B). In these three categories, as well as in the cell envelope
biosynthesis category, several operons for which most genes were
attenuated were identified, eg, the amiACDEF operon, the mntABC
operon, the pst operon and the aroDEBC operon (Table S1). The
amiACDEF operon encodes a multicomponent oligopeptide
transporter in S. pneumoniae [27]. Oligopeptides are an important
source of nutrients, but can also serve as signals for intercellular
communication. In a murine model of pneumococcal coloniza-
tion, deletion of ami genes resulted in pneumococci that were less
able to colonize the nasopharynx [28]. While the oligopeptide
transport systems are involved in the uptake of nutrients from the
external environment, the aro genes are involved in the biosyn-
thesis of aromatic amino acids [29]. Since the concentration of
amino acids in saliva is low [15], their biosynthesis is likely to
become more important, which explains the observed decrease in
survival of the aro mutants in our screen.
Table 1. Cont.
Strain, primer or plasmid Relevant features or nucleotide sequence (59 to 39)a Reference/source or target geneb
PBGSF30 ATCACG P-CGTGATAGATCGGAAGAGCGTCGTGTAGGGAAAGAGT-P Adapter primer [14]
PBGSF29 CGATGT TTCCCTACACGACGCTCTTCCGATCTCGATGTNN Adapter primer [14]
PBGSF30 CGATGT P-ACATCGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGT-P Adapter primer [14]
PBGSF29 TTAGGC TTCCCTACACGACGCTCTTCCGATCTTTAGGCNN Adapter primer [14]
PBGSF30 TTAGGC P-GCCTAAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGT-P Adapter primer [14]
PBGSF29 TGACCA TTCCCTACACGACGCTCTTCCGATCTTGACCANN Adapter primer [14]
PBGSF30 TGACCA P-TGGTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGT-P Adapter primer [14]
PBGSF31 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT GSF amplification primer 2 [14]
aUnderlined sequences are complementary to primers used for amplification of antibiotic resistant cassettes.
bLeft flank and right flank indicate positions relative to the target gene.
doi:10.1371/journal.pone.0089541.t001
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The pst operon of S. pneumoniae encodes an ATP-binding cassette
phosphate transporter [30]. The uptake of phosphate is of
fundamental importance because phosphate is required as a
nutrient in the cell physiology of S. pneumoniae. Mutants of pst,
unable to transport phosphate over the cell membrane, are less
able to take up available phosphate from the saliva which is a likely
reason for their underrepresentation in human saliva.
Following these hypotheses concerning the potential roles of
plsX, amiACDEF, aroDEBC and pst in pneumococcal survival and/
or growth in saliva, we suggest that a limited presence of certain
essential nutrients, such as fatty acids, oligopeptides and
phosphate, in human saliva can result in a decreased resistance
of S. pneumoniae to lytic enzymes when genes coding for nutrient
biosynthesis or uptake are inactivated. The exact composition of
human saliva varies between individuals and with changes in
salivary flow [31]. Anti-pneumococcal antibodies may also be
present in human saliva, especially in children [2,3], and the
influence of specific salivary components on the survival and
transmission of S. pneumoniae through saliva warrants further
investigation.
Manganese is relatively accessible in the human nasopharynx
and has been measured at about 36 mM in saliva [32]. The psa
operon encodes an ATP-binding cassette transporter for manga-
nese uptake. In pneumococci, manganese transport by this
Figure 2. Single and competitive growth characteristics of S. pneumoniae strains in human saliva. A. Growth characteristics of several S.
pneumoniae strains in human saliva. Strains were incubated in 100% saliva at RT without CO2 (left) or at 37uC with CO2 (right) for 24 h. Viable bacterial
counts are presented as the percentage of the viable bacterial counts detected at t = 0 h. Each point represents a single measurement. Horizontal
lines indicate geometric means. B. Competitive growth between wild-type Spain9V-3 and its unencapsulated derivative Spain9V-3 Dcps. A 1:1 ratio of
the wild-type and its unencapsulated mutant was inoculated in 100% saliva at 37uC with CO2 and at RT without CO2. Competitive index scores (CI)
were determined at t = 4 h and at t = 24 h. Experiments were performed in quadruplicate. Each point represents the log competitive index score of a
single measurement. Horizontal lines represent the mean.
doi:10.1371/journal.pone.0089541.g002
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receptor is important for pneumococcal competence and virulence
[33,34]. In addition, psaA mutant strains exhibit increased
sensitivity to oxidative stress [35]. Considerable levels of antiox-
idants are found in human saliva, indicating the presence of
oxidative stress in the oral cavity [36]. The uptake of manganese
for protection against oxidative stress will thus be important for
survival of S. pneumoniae in saliva, which may explain the decreased
survival of mutants with a defect mntABC gene in our study.
Although the concentration of manganese in saliva is considerable,
it is restricted to nanomolar amounts at internal sites [32,37,38].
Manganese could thus be an important cue by which the
immediate environment is sensed and the transitioning to internal
body sites is experienced. Indeed, in clinical S. pneumoniae strains
from Chinese patients, psaA expression was significantly higher in
blood-derived than in sputum-derived S. pneumoniae [34]. Expres-
sion of psaA may thus be involved in invasion of the blood system
by S. pneumoniae, making this gene a potentially interesting target
for the development of new classes of antimicrobials.
Among the stress response genes, several genes that play a role
in the chaperone system were identified, eg, mecA, hslO, tigS and
clpB [39–42]. In eubacteria, the chaperone system and the
chaperones form a functional network, which assists the folding
of newly synthesized proteins [43]. Under stress conditions,
unfolded and misfolded proteins may be generated, which escape
this chaperone network and accumulate as protein aggregates.
ClpB, a member of the HSP100/Clp family [44], has the capacity
to facilitate the efficient disaggregation and refolding of a large
variety of protein aggregates in vitro and in vivo [40,45]. Possibly,
saliva represents a stress condition under which misfolded proteins
are generated. ClpB could thus be important for the refolding of
protein aggregates, which explains its potential role in the survival
of S. pneumoniae in saliva.
Characterization of Tn-seq identified genes that are
essential for survival of S. pneumoniae in saliva
For validation of the Tn-seq phenotypes, directed gene deletion
mutants were generated in S. pneumoniae Spain9V-3 for represen-
tatives from the two main categories: plsX and amiACDEF
(belonging to the categories of respectively cell envelope biosyn-
thesis and transport) and for the largest operon for which multiple
genes were selected in any of the other functional categories, ie,
aroDEBC. Survival of these mutants in saliva under the two
challenge conditions was assessed both during single growth, as
well as in competition with the wild-type.
In single culture experiments at RT without CO2, the plsX
mutant showed a trend towards a decreased survival compared
with the wild type at t = 24 (p = 0.056). The amiACDEF and
aroDEBC mutant strains did not show significantly decreased
survival compared to the wild type at any time point (Figure 4A).
After 24 h at 37uC in a CO2-rich environment, all three mutant
strains displayed decreased survival compared with the wild- type
strain (Figure 4A). However, this was only significant for the
aroDEBC mutant (p = 0.032).
Competition experiments showed that the wild-type strain
outcompeted DamiACDEF, DaroDEBC and DplsX at t = 24 h at
37uC in a CO2-rich environment (Figure 4B) corroborating the Tn
seq results, and this was statistically significant for DamiACDEF and
DplsX. At RT without CO2, only the DplsX mutant outcompeted
the wild-type at t = 24 h with a log CI score of 20.78, but this was
not statistically significant. These results are in accordance with
the Tn-seq screening, because mutants of the plsX gene showed
attenuation at RT without CO2 with a log fold-ratio #21.0,
whereas mutants of amiACDEF and aroDEBC did not show
attenuation at RT without CO2 (Table S1).
The finding that the competition assays confirmed the Tn-seq
results, while no difference was observed between growth of the
wild-type compared with the mutants in single culture experiments
for plsX and amiACDEF can be explained by the fact that the Tn-
seq screening is performed on a mutant library containing a
diverse collection of single insertion mutants. The setup of the Tn-
seq screening is therefore more comparable to the competition
assay than to the single culture assay.
Figure 3. Genes affecting survival of S. pneumoniae in human saliva. A. Overlap between genes identified by Tn-seq as important for survival
of S. pneumoniae in saliva at RT without CO2 or at 37uC with CO2. B. Biological properties and molecular functions of genes identified by the Tn-seq
screen as essential for pneumococcal growth and/or survival in saliva. The numbers of genes within each category are indicated.
doi:10.1371/journal.pone.0089541.g003
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Conclusions
In this study, we demonstrated that various clinically relevant S.
pneumoniae strains showed both survival and growth in saliva under
conditions representing in-host carriage (37uC with 5% CO2) and
transmission (RT without CO2). Additionally, we applied the Tn-
seq technology to gain insight into the genetic requirements of
pneumococcal growth in saliva, and showed that particularly
genes involved in cell envelope biosynthesis, transport, stress
response and amino acid metabolism play a role in this process.
The observation that pneumococci survive and grow in human
saliva underscores that S. pneumoniae can be transmitted via
respiratory droplets. The results described in this study provide a
basis for future investigations characterizing the survival and
pathogenesis of S. pneumoniae in human saliva.
Figure 4. Survival of directed gene deletion mutants in human saliva. A. Single growth experiments. A starting concentration of 106 CFU
ml21 wild-type or mutant bacteria was incubated with saliva at the two conditions. Median and interquartile range (IQR) of the CFU at each time
point are displayed. After 24 h at 37uC with CO2, all mutant strains showed decreased survival, but this was only statistically significant for DaroDEBC.
B. Competitive growth experiments. A 1:1 ratio of the wild type strain and the mutant strain (5*105 CFU ml21 for each strain) was inoculated in saliva.
Each black point represents the log competitive index score of an individual experiment. Values ,0 indicate attenuation of the mutant strain.
Horizontal lines represent the mean. After 24 h at 37uC with CO2, the wild-type strain outcompeted all mutant strains, but this was only statistically
significant for DamiACDEF and DplsX.
doi:10.1371/journal.pone.0089541.g004
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Methods
Ethics statement
Saliva from healthy adult volunteers was collected after
obtaining verbal informed consent in the presence of the study
team. Written informed consent was not obtained because
sampling was non-invasive. The research ethics committee of the
Radboud University Medical Centre approved the study protocol
and informed consent procedure.
Pneumococcal strains and growth conditions
All pneumococcal strains used in this study are shown in
Table 1. S. pneumoniae Spain9V-3 (SP195, PMEN No. 3) was used
for the generation of S. pneumoniae transposon mutant libraries
since this was a PMEN strain and thus isolated from patients with
pneumococcal disease from several parts of the world [12].
Furthermore, the Spain9V-3 strain showed survival after 24 h at
RT and growth after 24 h at 37uC with geometric mean viable
bacterial counts at t = 24 h around or above 100% of the bacterial
starting inoculum (Figure 2). S. pneumoniae strains were routinely
grown in Brain Heart Infusion (BHI) broth unless indicated
otherwise or on blood agar (BA) plates composed of Columbia
agar (Oxoid, Hampshire, United Kingdom) supplemented with
5% defibrinated sheep blood (Biotrading, Mijdrecht, Netherlands).
All cultures were incubated in a 5% CO2 incubator at 37uC. S.
pneumoniae freezer stocks were prepared from cultures grown to
mid-log phase until an optical density at 620 nm (OD620) between
0.2 and 0.3 and stored with 15% glycerol at -80uC. Viable
bacterial counts were determined by plating serial 10-fold dilutions
in PBS on BA plates. S. pneumoniae mutant libraries and directed
mutants were selected with BA plates containing 150 mg ml21
spectinomycin.
Generation of S. pneumoniae transposon mutant libraries
S. pneumoniae Spain9V-3 mariner transposon mutant libraries were
generated essentially as described previously [46]. Briefly, 1 mg of
pneumococcal genomic DNA was incubated in the presence of
purified Himar1 transposase and 1 mg of plasmid pGSF8 as a
donor of the mariner transposon conferring spectinomycin resis-
tance. After repair of the resulting transposition products, 100 ng
mutagenized DNA was used for transformation of 100 ml
competent S. pneumoniae cells. For mutant libraries, the required
number of colonies was scraped from the plates, pooled, grown to
mid-log phase and stored in 15% glycerol at 280uC.
Identification of genes essential for S. pneumoniae
survival in and transmission through saliva by Tn-seq
analysis
For the Tn-seq screen, the S. pneumoniae Spain9V transposon
mutant library was first pre-cultured until mid-log phase.
Approximately 106 CFU of the mutant library were inoculated
into 1 ml saliva, and incubated either at 37uC with 5% CO2 for
4 h or at RT without CO2 for 24 h (n= 4 for each condition).
After challenge, samples were supplemented with 15% of glycerol
and stored at 280uC. Equivalent CFUs of the recovered libraries
and the start library were expanded to mid-log, and chromosomal
DNA was isolated using Genomic-tip 20/G columns.
Tn-seq data analysis
The Tn-seq technology was used to profile the relative
abundance of each mutant in the library before and after
challenge as described previously [14]. For Tn-seq data analysis,
FASTQ files were processed via the ESSENTIALS data analysis
pipeline (http://bamics2.cmbi.ru.nl/websoftware/essentials/
essentials_start.php) [47]. Tn-seq bar code sequences were used
to attribute sequence reads to individual samples. Sequence reads
were aligned to the Spain9V-3 genome (accession number
NZ_ABGE00000000) with a minimum match of 16 nucleotides
and collected per unique insertion site (TA dinucleotide sequence)
and per gene. The number of unique transposon insertion sites
was defined as the positions that had at least 8 ‘‘pseudo’’ sequence
reads in the initial ‘‘start’’ library after normalization. In total
26,289 unique mutants where found. Selection criteria for genes of
which mutants were affected by the presence of saliva were as
follows: (1) a log2 fold-change in sequence reads between the start
library and the library challenged with saliva (either for 24 h at
RT or for 4 h at 37uC+5%CO2) #21 or $1 and a Benjamini-
Hochberg adjusted p-value ,0.05; (2) a minimum number of
reads in the start library of 100; and (3) a fitness score.23.5, with
the fitness score defined as the ratio between actual measured
sequence reads and expected sequence reads based on possible
TA-insertions sites and library size [47].
Genes were assigned to the functional categories transport, cell
envelope biosynthesis, stress response, amino acid metabolism,
translation and transcription, carbohydrate metabolism, nucleo-
tide metabolism, cell division and vitamin biosynthesis based on
the involvement of their encoded proteins or their orthologs in
these processes.
Construction of S. pneumoniae deletion mutants
Directed-deletion mutants of S. pneumoniae were generated by
allelic exchange of the target gene with an antibiotic resistance
marker as described previously using a megaprimer polymerase
chain reaction (PCR) method [46]. In short, an extension PCR
was performed to join 400–500 bp 59and 39 flanking sequences of
the target gene with the spectinomycin resistance cassette
(obtained from pR412T7), which was subsequently transformed
into naturally competent S. pneumoniae Spain9V-3 bacteria grown in
CTM medium. Next, 100 ng of DNA of the first-generation
directed mutants was crossed back into the S. pneumoniae Spain9V-3
wild-type strain and selected on spectinomycin plates. At the same
time, competent cells were also processed through the transfor-
mation procedure without the addition of DNA to obtain a
coupled wild-type strain. All primers used in this study (obtained
from Biolegio, Nijmegen, The Netherlands) are shown in Table 1.
Deletion of genes from mutants was confirmed by quantitative
real-time polymerase chain reaction (qRT-PCR) expression
analyses. To this end, strains were grown to OD620nm ,0.5 in
THY medium and RNA was isolated as previously described [48].
DNA-free total RNA (500 ng) was reverse transcribed into cDNA
using the iScript kit (Bio-Rad). qRT-PCR was performed using
SYBR green chemistry on a CFX-96 real-time PCR machine (Bio-
Rad). For all mutants, expression of the deleted gene(s) was
abolished, while expression levels of the reference gene gyrA were
comparable to the wild-type.
Saliva collection
Saliva from healthy volunteers was collected in the early
morning after overnight fasting from 11 pm the night before. Oral
hygiene was performed not closer than three hours before
collection of saliva. After collection, the saliva of at least two
donors was pooled, put on ice and centrifuged at 16,000 g and
4uC for 15 minutes. The supernatant was sterilized by ultrafiltra-
tion with 0.45 mm filters (Whatman, Dassel, Germany). The
sterility of the saliva was verified by incubation of a small portion
on BA plates for 48 h at 37uC.
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Evaluation of the survival and competitive growth of S.
pneumoniae strains in human saliva
For survival assay analyses, a starting concentration of 106 CFU
ml21 bacteria was incubated with saliva at two conditions: 37uC
with 5% CO2 and room temperature (RT) without CO2. At t = 0,
t = 2, t = 4, t = 6 and t = 24 h samples were taken for CFU count.
For competition experiments, a 1:1 ratio of the wild type strain
and the mutant strain (5*105 CFU ml21 for each strain) was
inoculated in saliva. At the same time points as those used for the
single cultures, the total number of bacteria was enumerated by
plating serial dilutions on blood agar plates and the number of
mutant bacteria was enumerated by plating serial dilutions on
spectinomycin plates. Experiments were performed in triplo,
quadruple or pentuple.
For competition experiments, a competitive index (CI) score was
calculated as the output ratio of the viable bacterial counts of
mutant to wild type bacteria divided by the input ratio of mutant
to wild type bacteria. A log CI score of ,0 indicates that the
mutant is outcompeted by the wild type. For samples in which no
viable bacteria were recovered, the lower limit of detection
(222 CFU ml21) was substituted as the numerator.
Statistical analysis
Statistical differences in growth of S. pneumoniae strains were
assessed using unpaired Student’s t tests or the nonparametric
Mann-Whitney’s tests depending on whether or not the log10
transformed values of viable bacterial counts were normally
distributed (Kolmogorov-Smirnov’s test, p.0.05). Statistical dif-
ferences in growth of S. pneumoniae in multiple dilutions of saliva
were assessed by a one-way analysis of variance (ANOVA) and
Tukey post hoc tests. For the competitive growth experiments, a
one-sample t test on log-transformed CI scores (with an arbitrary
mean of 0 and a p-value of ,0.05) was used to calculate statistical
significance.
Supporting Information
Table S1 Genes of S. pneumoniae of which transposon
mutants showed attenuated or enhanced survival and/
or growth in human saliva, categorized by functional
class.
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